AstraZeneca Thailand Launches NCD Certification Programme to Enhance Chronic Disease Care

The signing ceremony took place at the W Hotel, Bangkok, on Friday, 4th October. It was followed by a special session titled "ACT on NCD," where esteemed faculty members shared their vision for advancing the management of chronic NCDs in Thailand. The session highlighted the strategic direction of ACT on NCD, focusing on building the capacity of healthcare organisations and units to elevate care quality for patients suffering from chronic diseases.

The "NCD Certification Programme" represents a unique collaboration between leading healthcare organisations, each committed to raising the standards of chronic disease care. AstraZeneca Thailand, alongside its partners, aims to drive sustainable healthcare solutions, particularly in addressing the rising burden of NCDs in Thailand's ageing society.

Roman Ramos, Country President of AstraZeneca Thailand and Frontier Markets, stated: "The launch of the NCD Certification Programme marks a significant step forward in our collective effort to improve chronic disease care in Thailand. By collaborating with esteemed partners across the healthcare sector, we aim to foster a supportive environment where healthcare providers have access to resources and shared information to offer exemplary care. Our shared vision is to enhance early diagnosis and effective management of chronic diseases, ensuring that patients benefit from the best possible health outcomes and a higher quality of life."

Assoc.Prof. Petch Rawdaree, President of Thai NCD Alliance said "The association's vision is to effectively control and prevent non-communicable diseases (NCDs) for the maximum benefit of society. It aims to raise public awareness by promoting activities that reduce risk factors and enhance protective factors essential for disease prevention. Through policy advocacy and health literacy efforts, the association seeks to drive significant behavioural changes for better health outcomes. With NCD cases doubling in the past 20 years—especially among working-age individuals—there is an urgent need to expand public health services to manage the rising number of patients."

"One key project is a decade-long initiative to prevent and delay chronic kidney disease, involving both public and private sectors. This programme targets high-risk groups, such as those with diabetes and hypertension, under the Department of Disease Control's policy to improve the health of Thai people." Dr. Krisada Hanbunjerd, Director, Division of Non-Communicable Diseases, Department of Disease Control, Ministry of Public Health, Thailand Added

The initiative centres on seven educational webinars, each focused on a major chronic disease: diabetes, hypertension, dyslipidemia, chronic kidney disease, asthma, chronic obstructive pulmonary disease, and cancer screening. These webinars will provide healthcare professionals with up-to-date insights on risk assessment, screening, diagnosis, treatment guidelines, and complication management, adhering to national and international standards.

The programme fosters knowledge exchange and equips healthcare providers with practical, actionable insights for clinical practice. It aligns with the Ministry of Public Health's key objectives and regional NCD service goals, focusing on both prevention and treatment. By providing tools for early detection and comprehensive care, the initiative ensures healthcare professionals can offer the best possible outcomes for chronic disease management.

• ข่าว AstraZeneca